ARS Pharmaceuticals Inc (SPRY)
13.38
-0.17
(-1.25%)
USD |
NASDAQ |
Nov 21, 16:00
13.25
-0.13
(-0.97%)
Pre-Market: 09:28
ARS Pharmaceuticals Shareholders Equity (Quarterly): 200.98M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 200.98M |
| June 30, 2024 | 215.24M |
| March 31, 2024 | 223.87M |
| December 31, 2023 | 230.76M |
| September 30, 2023 | 237.28M |
| Date | Value |
|---|---|
| June 30, 2023 | 248.55M |
| March 31, 2023 | 261.16M |
| December 31, 2022 | 272.89M |
| June 30, 2022 | -44.03M |
| December 31, 2021 | -31.27M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-44.03M
Minimum
Jun 2022
272.89M
Maximum
Dec 2022
181.54M
Average
227.31M
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis Inc | 2.275B |
| Assembly Biosciences Inc | 26.00M |
| Protagonist Therapeutics Inc | 531.92M |
| Precision BioSciences Inc | 64.87M |
| Avidity Biosciences Inc | 1.503B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 217.60M |
| Total Liabilities (Quarterly) | 16.62M |
| Current Ratio | 12.56 |